Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
-1.77%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$54B
AUM Growth
-$3.22B
(-5.6%)
Cap. Flow
-$953M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.72%
Holding
985
New
115
Increased
314
Reduced
359
Closed
149
Top Buys
| 1 |
Hubbell
HUBB
|
+$208M |
| 2 |
Norfolk Southern
NSC
|
+$145M |
| 3 |
Insmed
INSM
|
+$137M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$136M |
| 5 |
Soleno Therapeutics
SLNO
|
+$116M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$355M |
| 2 |
Royalty Pharma
RPRX
|
+$334M |
| 3 |
McDonald's
MCD
|
+$198M |
| 4 |
Union Pacific
UNP
|
+$188M |
| 5 |
HES
Hess
HES
|
+$182M |
Sector Composition
| 1 | Technology | 26.31% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
NRG Energy
NRG
$31.2B
| $17.6M | 0.03% |
184,852
-104,400
| -36% | -$9.97M |
|
452
Pegasystems
PEGA
$9.66B
| $17.4M | 0.03% |
500,000
+270,000
| +117% | +$9.39M |
|
453
Darden Restaurants
DRI
$24.7B
| $17.3M | 0.03% |
+83,343
| New | +$17.3M |
|
454
Heron Therapeutics
HRTX
$195M
| $17.3M | 0.03% |
7,852,000
-648,000
| -8% | -$1.43M |
|
455
Bio-Techne
TECH
$7.93B
| $17.3M | 0.03% |
294,300
-204,200
| -41% | -$12M |
|
456
NiSource
NI
$19.2B
| $17.2M | 0.03% |
428,862
-7,300
| -2% | -$293K |
|
457
Safety Insurance
SAFT
$1.09B
| $17.1M | 0.03% |
217,000
+64,000
| +42% | +$5.05M |
|
458
Global Payments
GPN
$20.6B
| $17M | 0.03% |
173,960
-44,300
| -20% | -$4.34M |
|
459
BrightSpring Health Services
BTSG
$4.97B
| $17M | 0.03% |
939,529
+556,152
| +145% | +$10.1M |
|
460
Teledyne Technologies
TDY
$25.6B
| $17M | 0.03% |
34,067
-11,475
| -25% | -$5.71M |
|
461
Saia
SAIA
$8.19B
| $16.8M | 0.03% |
+48,106
| New | +$16.8M |
|
462
Precigen
PGEN
$1.22B
| $16.8M | 0.03% |
11,276,000
+410,595
| +4% | +$612K |
|
463
Tyson Foods
TSN
$19.7B
| $16.7M | 0.03% |
261,155
+45,100
| +21% | +$2.88M |
|
464
Protagonist Therapeutics
PTGX
$3.59B
| $16.6M | 0.03% |
+343,504
| New | +$16.6M |
|
465
Clorox
CLX
$15.1B
| $16.6M | 0.03% |
112,453
+55,600
| +98% | +$8.19M |
|
466
Labcorp
LH
$22.7B
| $16.3M | 0.03% |
70,100
+27,456
| +64% | +$6.39M |
|
467
Highwoods Properties
HIW
$3.44B
| $16.3M | 0.03% |
549,136
+218,980
| +66% | +$6.49M |
|
468
Deckers Outdoor
DECK
$16.9B
| $16.3M | 0.03% |
145,383
+3,483
| +2% | +$389K |
|
469
Landstar System
LSTR
$4.5B
| $16.1M | 0.03% |
107,000
+30,000
| +39% | +$4.51M |
|
470
Allete
ALE
$3.7B
| $16M | 0.03% |
244,281
-520,007
| -68% | -$34.2M |
|
471
Remitly
RELY
$3.89B
| $15.9M | 0.03% |
766,392
-143,608
| -16% | -$2.99M |
|
472
Fluor
FLR
$6.69B
| $15.9M | 0.03% |
+444,000
| New | +$15.9M |
|
|
BBOT
473
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$796M
| $15.8M | 0.03% |
1,400,000
| – | – |
|
474
General Motors
GM
$54.6B
| $15.7M | 0.03% |
333,086
-694,300
| -68% | -$32.7M |
|
475
Mirum Pharmaceuticals
MIRM
$3.76B
| $15.5M | 0.03% |
345,000
+195,000
| +130% | +$8.78M |
|